Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-16-076485)

Filing Details

Accession Number:: 0001144204-16-076485
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-01-21 15:55:00
Reporting Period:: 2016-01-19

Filing Date:: 2016-01-21
Accepted Time:: 2016-01-21 15:55:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
895051	Casi Pharmaceuticals Inc.	CASI	Biological Products, (No Disgnostic Substances) (2836)	581959440

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1545181	Keyong Ken Ren	Casi Pharmaceuticals, Inc. 9620 Medical Center Drive, Suite 300 Rockville MD 20850	Ceo And Director	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-01-19	7,537	$0.73	7,537	No	4	P	Direct
Common Stock	Acquisiton	2016-01-19	1,100	$0.74	8,637	No	4	P	Direct
Common Stock	Acquisiton	2016-01-19	6,063	$0.72	14,700	No	4	P	Direct
Common Stock	Acquisiton	2016-01-19	300	$0.71	15,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct